Renhe Pharmacy Co (SZSE:000650) COGS-to-Revenue : 0.63 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co COGS-to-Revenue?

Renhe Pharmacy Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥784 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥1,238 Mil.

Renhe Pharmacy Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.63.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Renhe Pharmacy Co's Gross Margin % for the three months ended in Mar. 2024 was 36.66%.

Renhe Pharmacy Co COGS-to-Revenue Historical Data

The historical data trend for Renhe Pharmacy Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co COGS-to-Revenue Chart

Renhe Pharmacy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.58

0.61

0.62

0.63

Renhe Pharmacy Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.61	0.64	0.62	0.66	0.63

Renhe Pharmacy Co COGS-to-Revenue Calculation

Renhe Pharmacy Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3164.092	/	5032.146
	=	0.63

Renhe Pharmacy Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	783.896	/	1237.638
	=	0.63

Renhe Pharmacy Co (SZSE:000650) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Renhe Pharmacy Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	783.896 / 1237.638
	=	36.66 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Renhe Pharmacy Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Renhe Pharmacy Co (SZSE:000650) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038

Website

http://www.renheyaoye.com

Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.

Renhe Pharmacy Co (SZSE:000650) Headlines

No Headlines